Bullous Pemphigoid (BP) Completed Phase 2 Trials for Mepolizumab (DB06612)

Also known as: Pemphigoid, Bullous / Bullous Pemphigoid / Pemphigoid / Bullous pemphigoid NOS

IndicationStatusPhase
DBCOND0074370 (Bullous Pemphigoid (BP))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01705795Anti-IL-5 Therapy in Bullous Pemphigoid (BP)Treatment